The New York Times reported that now-retired race horse Justify failed a drug test prior to the 2018 Kentucky Derby, the first of three races in the American Triple Crown.
The consequences that usually follow a failed drug test would be forfeiture of the prize money and disqualification. Instead, the California Horse Racing Board took weeks to confirm the positive results of the doping test, and ultimately dismissed the case, The Times said.
Visit Business Insider’s homepage for more stories.
Race horse Justify made history in 2018 by being the first colt, who did not race as 2-year-old, to win the 2018 Triple Crown in over a century.
However, documents uncovered by The New York Times Wednesday showed that the race horse failed a drug test prior to the Kentucky Derby, the first of three races in the American Triple Crown.
Chuck Winner, chairman of the California Horse Racing Board, owns financial interest in Justify and other horses trained by “Hall of Fame” trainer Bob Baffert, but The Times did not find evidence of “pressure or tampering by Justify’s owners.”
Justify was tested on April 7, 2018, the date of the Santa Anita Derby, which he won — a victory needed to qualify for the Kentucky Derby.
The samples were sent to the lab on April 10. The results revealed an “excessive” amount of scopolamine — a banned substance — in the horse’s system, suggesting that it was intentionally used.
The drug can “can act as a bronchodilator to clear a horse’s airway and optimize a horse’s heart rate, making the horse more efficient,” The Times wrote, citing Dr. Rick Sams, who previously worked in the drug lab for the Kentucky Horse Racing Commission. In humans it is used to treat stomach issues.
The consequences that usually follow a failed drug test would be forfeiture of …read more
Source:: Business Insider